Okufuneka Ukwazi Ngokuthatha iMetformin Ukuba Unayo i-PCOS
Ukuba unayo i-Polycystic Ovary Syndrome (i- PCOS ) kwaye imiselwe i-metformin, amathuba ukuba unemibuzo eninzi kunye nexhala malunga nokuthatha le mayeza. Ininzi yabasetyhini abane-PCOS banamaqondo aphakamileyo e-insulin abangela ukuzuza ubunzima, ukuthanda, kunye neentlanzi ezimnyama esikhumbeni sakho. Ngokuhamba kwexesha, ukufikelela kwizinga eliphezulu le-insulin kunokukwenza ukuba u- insulin unqande okanye uguquke ube ngumhlobo wesifo sikashukela .
I-Metformin isebenza ukunciphisa i-insulin yakho kwaye unciphise umngcipheko wakho wesifo sikashukela.
Eli nqaku liza kukubonisa oko kufuneka ukwazi malunga nokuthatha i-metformin ukuba unayo i-PCOS.
I-Metformin isebenza njani?
I-Metformin yenye yezilwanyana ezindala kunye nezifundo ezininzi ezifunyenweyo e-United States. Amanye amagama e-metformin afaka i-Glucophage, i-Glucophage XR, i-glumetza, ne-fortamet. Nangona kungabhalwa ukusetyenziswa kwabasetyhini nge-PCOS, i-metformin yenye yeyeza eziqhelekileyo ezisetyenziswa ukulawula imeko. I-Metformin iye yafundiswa kumantombazana aselula njengeminyaka eyi-8 ubudala, kunye nabaphandi abathile bacebisa ukukhusela ukuqala kwe-PCOS. I-Metformin isebenza njenge- insulin-sensitizer ukunciphisa imveliso yakho ye-glucose. I-Metformin inciphisa i-blood glucose kunye namazinga e-insulin ngeendlela ezintathu:
1. Ikhupha imveliso yesibindi ye-glucose.
2. Ukwandisa ububele besibindi sakho, isisu, amafutha kunye neeseli kumzimba wakho we-insulin.
3. Iyancipha ukuxutywa kwe- carbohydrates oyidlayo.
Umlinganiselo wesilinganiso se-metformin kubasetyhini abane-PCOS ngu-1,500 mg ukuya kwi-2,000 mg imihla ngemihla.
Izinzuzo zezeMpilo zeMetformin
Ngaphandle kokunciphisa i-glucose kunye namazinga e-insulin, i-metformin inokubonelela ngezinye iinkonzo zempilo kubasetyhini abane-PCOS. I-Metformin inokuphucula i-ovulation kwaye ilawula imijikelezo yesini.
Oku kuthetha ukuba usebenza ngesondo, kufuneka usebenzise ukulawulwa kokuzalwa ukukhusela ukukhulelwa, nokuba ungekho ixesha lakho rhoqo. I-Metformin inokuphucula i-cholesterol kunye neempawu ze-hirsutism ezinjenge-acne kunye nokukhula kweenwele ezingaphezulu. I-Metformin inokukunceda ekulahlekeni kwesisindo xa ihamba kunye nokutya okunempilo kunye nokuzivocavoca kodwa asiyiyo imithi yokulahleka kwesisindo. Ukuthatha i-metformin xa ukhulelwe kunokunciphisa umngcipheko wesifo sikashukela kwaye kufuneka ukuxoxwa nodokotela wakho.
Kuthiwani Ngeempembelelo Zecala?
Ngokubanzi, abaninzi abantu banokunyamezela i-metformin ngokufanelekileyo. Iziphumo eziqhelekileyo ezichaphazelekayo xa uqale uthabatha i-GI ehlobene kwaye ingabandakanywa isisulu, i-gesi, ukubhubhisa, ukuphuka kwesisu kunye nesifo sohudo. Abanye abantu bafumanisa ukuba ukukhutshwa kwe-metformin eyongezelelekileyo kwindlela yokutya kunye nokunyamezeleka.
I-Metformin kufuneka ithathwe ngokutya ukunciphisa imiphumo yecala. Ukunyuka kancinci umthamo we-metformin kwiiveki eziliqela kunconywa kwiziphumo ezilungileyo. Ukutya okuneswekile kunye nokutya okucutshungulwa kunokudambisa umonakalo wegalelo lomzimba we-metformin kwaye kufuneka ugwenywe. Unokufumana usebenza kunye nesondlo sezondlo esondelene nesondlo esithile esisebenzisayo kwi-PCOS eyakuncedo ukudala isicwangciso sokutya esilungele ngakumbi kwiimfuno zakho ezizodwa.
I-Metformin inokuchaphazela ukuxutywa kwe- vitamin B12 . Ukusetyenziswa kwexesha elide kunye namanani aphakamileyo e-metformin kwandisa amathuba okuba ne-vitamin B12. Ukungabikho kwe-vitamin B12 kunokubangela ukuguquka kwemizwelo, ukulahlekelwa kwememori kwaye kungabangela umonakalo ongunaphakade kwingqondo kunye nenkqubo yesifo. Kufuneka uncedise ukutya kwakho nge-vitamin B12 kwaye amazinga akho ahlolwe rhoqo ngonyaka. Iimpawu ezifanelekileyo ze-vitamin B12 kufuneka zibe> 450 pg / mL. Iphakamileyo ye-serum homocysteine kunye ne-urinary methylmalonic acid (MMA), imilinganiselo yegolide ekuvavanyeni i-B12, ibonisa nokulahleka kwe-B12.
I-Lactic acidosis yintsikelelo engavumelekanga ye-metformin.
Ukusela utywala ngelixa i-metformin ayikhuthazwa.
Ngaba zikhona iindlela zeNdalo zeMetformin?
Akukho ndawo ithatha indawo ye-metformin kodwa kulabo bantu abangenakuyinyamezela okanye abangafuni ukuthatha imithi enqunyiwe, zikho ezinye iindlela zokuphucula ukuvakalelwa kwe-insulin ukuba unayo i-PCOS-ngaphandle kwemiphumo emibi. Eyona nto ibaluleke kakhulu kukulandela ukutya okunempilo kunye nokuzibandakanya emsebenzini oqhelekileyo. I-N-acetyl cysteine yintsholongwane eboniswa kwilingo elilodwa elilawulwa ngolu hlobo lokusebenza kunye ne-metformin ekunciphiseni i-insulin kunye ne-cholesterol kubasetyhini abane-PCOS. I-Myo-inositol yafunyanwa ukubuyisela i-ovulation eyenza ukukhulelwa okungaphezulu kune-metformin. I-Myo-inositol iye yaboniswa ukuphucula i-insulin kunye neminye imiba ye-PCOS.
> Imithombo:
> Bailey, C. no-Turner, R. Metformin. N Engl J Med. 1996; 334: 574-579
> Ibáñez L1, uLópez-Bermejo A, uDíaz M, Marcos MV, de Zegher F. I-Metformin Therapy (iminyaka eyi-8-12 iminyaka) kwiintombi ezinobuchwephesha obuphambili ukuze kuncitshiswe iHirsutism, i-Androgen eyongezelelekileyo, kunye ne-Oligomenorrhea kwi-Adolescence. J Clin Endocrinol Metab. Ngo-2011 Agasti; 96 (8): E1262-7. I-doi: 10.1210 / jc.2011-0555.
> Zhuo Z, Wang A, Yu H. Impembelelo ye-Metformin Intervention Ngethuba lokukhulelwa kwisifo sikashukela se-Gestational Mellitus kwabasetyhini abane-Polycystic Ovary Syndrome: uVavanyo oluHlolo kunye ne-Meta-Analysis. J Diabetes Res. 2014; 2014: 381231.
> I-Oner G, i-Muderris II. Iiklinikhi, i-Endocrine kunye neempembelelo zeMetabolic ze-Metformin vs N-Acetyl-Cysteine kumaTyhini nePolycystic Ovary Syndrome. I-Eur J I-Obstet Gynecol ihlawula i-Biol. 2011.
> I-Costantino D, i-Minozzi G, i-Minozzi E, i-Guaraldi C. I-Metabolic nemiphumo yeHormon ye-Myo-Inositol kwiBhinqa enePolycystic Ovary Syndrome: i-Trial-Blind Trial. I-Europ Ukuhlaziya iMed Pharmacol Sci. 2009; 13 (2): 105-110.
> Unfer V, uCarlomagno G, uRizzo P, uRaffone E, uRoseff S. Imetaboli kunye neHormonal Effects ye-Myo-Inositol kuBafazi abane-Polycystic Ovary Syndrome: i-Trial-Blind Trial. I-Europ Ukuhlaziya iMed Pharmacol Sci. 2011; 15 (4): 452-457.
> Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U. [Ukutya, i-Metformin kunye ne-Inositol kwi-Womenight Overseight and Obese Women With Polycystic Ovary Syndrome: Impembelelo kwiCandelo loMzimba]. Minerva Ginecologica. 2012; 64 (1): 23-29.
> Venturella R, Mocciaro R, De Trana E, D'Alessandro P, Morelli M, Zullo F. [Uvavanyo lokuguqulwa kweeNtsholongwane, i-Endocrinal kunye ne-Metabolical Profile of Patients With PCOS Syndrome ephathwayo nge-Myo-Inositol]. Minerva Ginecologica. 2012; 64 (3): 239-243.
> Genazzani AD, Prati A, Santagni S, et al. Impendulo ye-insulini eyahlukileyo kuMlawuli we-Myo-Inositol kwi-Obese Polycystic Ovary Syndrome Izigulane. Gynecol Endocrinol. 2012; 28 (12): 969-973.
> Gerli S, uPapaleo E, uFerrari A, uDi Renzo GC. I-Randomized, i-Blind Double Blind Indawo elawulwa yi-Placebo-Controled Trial: Iimpembelelo ze-Myo-Inositol kwiMisebenzi ye-Ovari kunye nezinto eziMetabolic kwi-Women with PCOS. I-Europ Rev Med Pharmacol Sci. 2007; 11 (5): 347-354.
> URaffone E, uRizzo P, uBenedetto V. I-insulin i-Agents Sensitiser Agents Yodwa kunye ne-Co-Treatment kunye ne-R-Fsh ye-Ovulation Induction kwi-Pcos Women. Gynecol Endocrinol. 2010; 26 (4): 275-280.
> Galazis N, Galazi M, Atiomo W. d-Chiro-Inositol kunye nokuBaluleka kwayo kwi-Polycystic Ovary Syndrome: UkuHlola okuHlolo. Gynecol Endocrinol. 2011; 27 (4): 256-62
> Papaleo, E., Unfer, V., Baillargeon, JP, et al. (2007). I-Myo-Inositol kwizigulane nge-Polycystic Ovary Syndrome: iNdlela yeNew ye-Ovulation Induction. I-Endocrinology ye-Gynecological, 23 (12): 700-703.